Chief Executive Officer
Chairman of Therapix’s Board of Directors since January 2014, Dr. Shmulewitz has also served as a Board member since February 2013. With doctorate degrees in medicine and engineering, Dr. Shmulewitz spent much of his career as a successful inventor, investor and serial entrepreneur in the biomedical technologies field, facilitating a wide range of corporate collaborations. He founded and invested in over twenty-four life science companies – many of which enjoyed successful exits via merger & acquisition transactions with large medical device companies – including Arteria Corp., Circulation Inc., Labcoat Medical Ltd., NeoVision Corp, and X-Cardia Inc. In 1995, Dr. Shmulewitz co-founded San Francisco Science and the Incumed Group which both provide seed funding to promising companies. He also founded the private Israeli investment firm and incubator Medgenesis Partners Ltd. which has invested in over a dozen ventures. Between 1988 and 1992, Dr. Shmulewitz held senior executive positions at Advanced Technology Laboratories Inc.. He received his M.D. from The Technion Medical School, and a Ph.D. in Engineering from Tel Aviv University, Israel.